Hepatitis E virus (HEV) has at least 2 distinct epidemiological profiles:(1) large outbreaks
and epidemics in developing countries, usually caused by HEV genotype 1, resulting in high …

Background Seroprevalence data suggest that a third of the world's population has been
infected with the hepatitis E virus. Our aim was to assess efficacy and safety of a …

Hepatitis E, which is caused by hepatitis E virus (HEV), may now be considered a zoonosis
as well as an anthroponosis. Pigs, boars and deer have been identified as reservoirs, and …

BACKGROUND & AIMS: Hepatitis E virus (HEV) infection can evolve to chronic hepatitis in
immunocompromised patients. Pegylated α-interferon can effectively treat chronic HEV …

This study assessed the effect of a 3-month course of pegylated interferon-α-2a (Peg-IFN-α-
2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was …

Abstract Background. Hepatitis E virus (HEV) infections can lead to chronic hepatitis in
immunocompromised patients. We have investigated the risk factors for HEV infection …

Background: There is currently no accepted treatment of chronic hepatitis E virus (HEV)
infection. Objective: To report 2 patients in whom ribavirin therapy seemed to alter the …

It has been shown that hepatitis E virus (HEV) may be responsible for chronic hepatitis in
solid‐organ transplant patients. It has also been suggested that HEV may be responsible for …

Hepatitis E virus (HEV) can induce chronic hepatitis in immunosuppressed patients. There is
no established treatment for HEV infection. Pegylated interferon-alpha-2a (Peg-IFN-α-2a) …

Background: Acute hepatitis E virus (HEV) infection is usually followed by complete
recovery, but some cases of chronic HEV infection have been reported. Objective: To report …